Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ:BDTX
Want to see BDTX full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 70.00M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 69.67M | $ 0.00 | $ -437.00K | $ 0.00 | $ 0.00 |
| Operating Income | $ 19.87M | $ -78.78M | $ -86.46M | $ -92.83M | $ -126.87M |
| EBITDA | $ 20.20M | $ -78.44M | $ -86.02M | $ -92.32M | $ -126.67M |
| Net Income | $ 22.37M | $ -69.68M | $ -82.44M | $ -91.17M | $ -125.60M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 128.65M | $ 98.58M | $ 131.40M | $ 122.81M | $ 209.79M |
| Total Assets | $ 143.01M | $ 122.64M | $ 158.57M | $ 156.25M | $ 247.68M |
| Total Debt | $ 15.07M | $ 22.19M | $ 25.30M | $ 28.14M | $ 28.46M |
| Net Debt | $ -5.92M | $ -14.25M | $ -30.92M | $ -6.17M | $ -37.34M |
| Total Liabilities | $ 30.80M | $ 39.35M | $ 41.83M | $ 40.56M | $ 51.78M |
| Stockholders' Equity | $ 112.21M | $ 83.28M | $ 116.74M | $ 115.69M | $ 195.90M |
| Cash Flow | |||||
| Free Cash Flow | $ 29.61M | $ -62.30M | $ -66.75M | $ -85.27M | $ -102.86M |
| Operating Cash Flow | $ 29.61M | $ -62.30M | $ -66.72M | $ -85.08M | $ -100.15M |
| Investing Cash Flow | $ -44.91M | $ 16.97M | $ 16.35M | $ 53.37M | $ 130.61M |
| Financing Cash Flow | $ -146.00K | $ 25.55M | $ 71.93M | $ 177.00K | $ 729.00K |